BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Business

  Kymera Emerges Out of Stealth Mode With $30M and a Top Team of Drug Hunters

  Kymera Therapeutics launched with a $30M Series A financing which was lead by Atlas Venture.

  October 30, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Deals

  Novartis Slams Down $3.9B for This French Cancer Biotech

  Fresh off the heels of its CAR-T approval, Novartis expanded its oncological arsenal with a $3.9B acquisition of Advanced Accelerator Applications.

  October 30, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  AstraZeneca Continues to Divest Assets, Takes Stake in Mereo BioPharma With New Deal

  Astra signed a licensing deal with Mereo BioPharma to out license the oral inhibitor of neutrophil elastase to the smaller Mereo.

  October 30, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  The Complicated Relationship Between Celgene and President Trump

  On multiple occasions, President Donald Trump has aimed his ire at pharma companies.

  October 30, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Deals

  Shire in Talks to Sell 100-Employee Facility in Massachusetts

  As part of consolidation program, Shire is looking to sell a manufacturing facility in Milford, MA that it gained through its 2015 acquisition of Baxalta.

  October 30, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Policy

  Insys Sales Execs Allegedly Made a Rap Video of Themselves Dancing With Their Deadly Fentanyl Spray

  Insys continues to receive an optics beating in the wake of the charges against company founder John Kapoor and multiple executives surrounding illegal sales practices of its cancer pain drug.

  October 30, 2017

   · 

  3 min read

   · 

  Alex Keown
• 

  Deals

  Fosun Pharma to Buy France’s Tridem for $73M

  Fosun Pharma said it would buy Tridem Pharma S.A.S. for $73M, in a move to expand its market share in Europe and Africa.

  October 30, 2017

   · 

  1 min read
• 

  BioForest

  Why Amazon Could be More Interested in Medical Devices Than Drugs

  Amazon, as most everyone knows, has its fingers in a lot of pies.

  October 30, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Job Trends

  This is the Fastest-Growing Private Pharma in the Bay Area

  Want to work for a company having a growth spurt?

  October 30, 2017

   · 

  1 min read
• 

  Startup Riverfield Surgical Robot Laboratory Scores $10M to Challenge Intuitive Surgical

  Riverfield plans to have its device on the Japanese market by 2020.

  October 30, 2017

   · 

  1 min read